(Q35586225)

9 August 2017

title

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women (English)

1 reference

9 August 2017

M A E Nobbenhuis

1

1 reference

9 August 2017

T J M Helmerhorst

2

1 reference

9 August 2017

A J C van den Brule

3

1 reference

9 August 2017

L Rozendaal

4

1 reference

9 August 2017

L H Jaspars

5

1 reference

9 August 2017

F J Voorhorst

6

1 reference

9 August 2017

R H M Verheijen

7

1 reference

9 August 2017

C J L M Meijer

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Journal of Clinical Pathology

9 August 2017

published in

1 reference

9 August 2017

volume

55

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

435-439

1 reference

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

Human papillomavirus testing in primary cervical screening.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

The effectiveness of cervical screening: a population-based case-control study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769675

Screening for cervical neoplasia by self-assessment for human papillomavirus DNA

26 September 2018

1 reference

12 December 2020

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

12 December 2020

[Recommendations in aberrant findings of cytological studies of the cervix uteri]

1 reference

12 December 2020

Inexpensive population screening for abnormal cells from the uterine cervix and valid results using the vaginal cytopipette

1 reference

12 December 2020

Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections

1 reference

12 December 2020

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

12 December 2020

Detection rates for abnormal cervical smears: what are we screening for?

1 reference

12 December 2020

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

1 reference

12 December 2020

The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995

1 reference

12 December 2020

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1 reference

12 December 2020

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.55.6.435

1 reference

9 August 2017

1 reference

9 August 2017

1 reference